Abstract
Neutrophilic dermatoses are rare in children. Systemic corticosteroids are the first-line treatment, but guidelines for second-line therapies are lacking. We report five cases of children with systemic steroid-resistant/dependent neutrophilic dermatoses, successfully treated with tumor necrosis factor inhibitors.